As we see more patients who have had Covid-19, we ask psychiatrist, Dr. Imaan Alaidroos, to speak with us about the neuropsychiatric impact of the disease. In this episode, Dr. Alaidroos explains the mechanisms behind the neuropsychiatric symptoms and the specific neuropsychiatric symptoms that have been associated with Covid-19. 

Hosts: Alan, Toshia

Guest: Imaan Alaidroos, MD

References:

1.Méndez, R, Balanzá-Martínez, V, Luperdi, SC, Estrada, I, Latorre, A, González-Jiménez, P, Feced, L, Bouzas, L, Yépez, K, Ferrando, A, Hervás, D, Zaldívar, E, Reyes, S, Berk, M, Menéndez, R (La Fe University and Polytechnic Hospital, Valencia; Health Research Institute La Fe, Valencia; University of Barcelona, Barcelona, University of Valencia, CIBERSAM, Valencia; La Fe University and Polytechnic Hospital, Valencia; University of Valencia, Valencia; Health Research Institute La Fe, Valencia, Spain; Barwon Health, Deakin University, Geelong; The University of Melbourne, Melbourne, Victoria, Australia; Center for Biomedical Research Network in Respiratory Diseases (CIBERES), Madrid, Spain). Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med 2021; 290: 621– 631.

2.Nakamura, Z. M., Nash, R. P., Laughon, S. L., & Rosenstein, D. L. (2021). Neuropsychiatric Complications of COVID-19. Current psychiatry reports, 23(5), 25. https://doi.org/10.1007/s11920-021-01237-9

3.Banerjee, D., & Viswanath, B. (2020). Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian journal of psychiatry, 54, 102350. https://doi.org/10.1016/j.ajp.2020.102350

4.Borah, P., Deb, P. K., Chandrasekaran, B., Goyal, M., Bansal, M., Hussain, S., Shinu, P., Venugopala, K. N., Al-Shar'i, N. A., Deka, S., & Singh, V. (2021). Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Frontiers in molecular biosciences, 8, 627723. https://doi.org/10.3389/fmolb.2021.627723

5.Jansen van Vuren, E., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021). The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomedicine & pharmacotherapy = Biomedecine& pharmacotherapie, 135, 111200. https://doi.org/10.1016/j.biopha.2020.111200

6.Roy, D., Ghosh, R., Dubey, S., Dubey, M. J., Benito-León, J., & Kanti Ray, B. (2021). Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 48(1), 9–24. https://doi.org/10.1017/cjn.2020.173